Table 1 Patient characteristics
Favorable (n = 12) | Unfavorable (n = 78) | Total (n = 90) | ||
|---|---|---|---|---|
Age in years | Median (range) | 68 (47–78) | 66 (34–83) | 66.5 (34–83) |
Sex, n (%) | Male | 2 (17) | 35 (45) | 37 (41) |
Female | 10 (83) | 43 (55) | 53 (59) | |
ECOG-PS, n (%) | 0 | 9 (75) | 36 (46) | 45 (50) |
1 | 2 (17) | 33 (42) | 35 (39) | |
2 | 1 (8) | 2 (3) | 3 (3) | |
3 | 0 | 6 (8) | 6 (7) | |
NA | 0 | 1 (1) | 1 (1) | |
Metastases, n (%) | Lymph node | 5 (42) | 53 (68) | 58 (64) |
Bone | 0 | 21 (27) | 21 (23) | |
Liver | 0 | 13 (17) | 13 (14) | |
Lung | 0 | 12 (15) | 12 (13) | |
Brain | 0 | 4 (5) | 4 (4) | |
The estimated primary organ, n (%) | Breast | 5 (42) | - | - |
Ovary/peritoneum | 5 (42) | - | - | |
Skin | 2 (17) | - | - | |